IRIS
NAVARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.587
NA - Nord America 840
EU - Europa 564
AF - Africa 22
SA - Sud America 18
OC - Oceania 11
Totale 6.042
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.643
US - Stati Uniti d'America 780
CN - Cina 497
HK - Hong Kong 347
GB - Regno Unito 142
IT - Italia 139
DE - Germania 81
NL - Olanda 60
CA - Canada 40
IN - India 37
FI - Finlandia 35
MX - Messico 20
JP - Giappone 18
TR - Turchia 18
AT - Austria 15
BR - Brasile 15
FR - Francia 15
PL - Polonia 13
ES - Italia 12
UA - Ucraina 12
AU - Australia 11
ZA - Sudafrica 11
EG - Egitto 9
LT - Lituania 9
DK - Danimarca 6
BD - Bangladesh 4
CZ - Repubblica Ceca 4
ID - Indonesia 4
SE - Svezia 4
BG - Bulgaria 3
EE - Estonia 3
IL - Israele 3
IR - Iran 3
RO - Romania 3
VN - Vietnam 3
CO - Colombia 2
PH - Filippine 2
RU - Federazione Russa 2
TL - Timor Orientale 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BJ - Benin 1
CH - Svizzera 1
IE - Irlanda 1
IS - Islanda 1
KR - Corea 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 6.042
Salva come PNG Salva come JPEG
Città #
Hong Kong 343
Singapore 257
Hefei 256
Ashburn 182
Boardman 134
London 120
Shanghai 81
Council Bluffs 73
Beijing 65
Amsterdam 51
Munich 50
Rome 41
Los Angeles 36
Turku 22
Santa Clara 21
Toronto 17
Ankara 16
San Francisco 16
Bari 15
Washington 15
Pune 14
Tokyo 14
Brooklyn 13
New York 13
Helsinki 12
Warsaw 12
Chennai 11
Hangzhou 10
Mexico City 10
Atlanta 9
Boston 9
Seattle 9
Chicago 8
Jinan 8
Nuremberg 8
Qingdao 8
West Jordan 8
Changsha 7
Guangzhou 7
Jaguariúna 7
Johannesburg 7
Montreal 7
Charlotte 6
Dallas 6
Las Vegas 6
Melbourne 6
Naples 6
Milan 5
Paris 5
Pisa 5
São Paulo 5
Brno 4
Chaozhou 4
Kongens Lyngby 4
Noicattaro 4
Secaucus 4
State College 4
Stockholm 4
Xi'an 4
Chengdu 3
New Delhi 3
Poplar 3
Redmond 3
Sydney 3
Tel Aviv 3
Vienna 3
Alexandria 2
Anantapur 2
Bosco Marengo 2
Brest 2
Brisbane 2
Burlington 2
Cairo 2
Calgary 2
Cuernavaca 2
Denver 2
Dili 2
Fisciano 2
Frankfurt am Main 2
Groningen 2
Guiyang 2
Haikou 2
Herne Bay 2
Ho Chi Minh City 2
Honolulu 2
Madrid 2
Manchester 2
Markham 2
Monterrey 2
Narashino Shi 2
Newark 2
Newcastle-under-Lyme 2
Philadelphia 2
Prayagraj 2
Quarto 2
Reus 2
Richmond 2
San Jose 2
Shijiazhuang 2
Sofia 2
Totale 2.193
Salva come PNG Salva come JPEG
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 195
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 194
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 192
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 189
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 181
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 174
Leptin in immuno-rheumatological diseases 169
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 168
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 163
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 161
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 149
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 135
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 122
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 118
Adult-onset Still's disease with elderly onset: results from a multicentre study 103
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 103
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 95
A longitudinal study on caring behaviors of Italian nursing students 88
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 87
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 86
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 86
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 85
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 85
Cannabinoids in Autoimmune and Rheumatic Diseases 84
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 83
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 83
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 82
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 81
Leptin in autoimmune mechanisms of systemic rheumatic diseases 80
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 77
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 75
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 63
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 62
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 60
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 59
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 55
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 54
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 44
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 43
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 39
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 38
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 36
Development and implementation of the AIDA International Registry for patients with Behçet's disease 35
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 32
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 31
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 31
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 31
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 30
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 30
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 30
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 30
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 29
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 29
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 28
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 27
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 27
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 27
Polypharmacy is a determinant of hospitalization in Parkinson's disease 27
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 26
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 26
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 26
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 26
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 25
Matters of the heart: The case of TNF-alpha targeting drugs 25
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 25
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 25
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 25
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 24
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 24
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art 24
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 24
Endothelial-to-mesenchymal transition in systemic sclerosis 24
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 23
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 23
Utility of ultrasound in the diagnosis of chronic worsened gout 22
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 22
Pathogenesis of Psoriatic Arthritis 22
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 22
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 22
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 22
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 22
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 22
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 22
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 21
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 21
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 21
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 21
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 21
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 21
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 20
Serum level of endostatin and digital ulcers in systemic sclerosis patients 20
Systemic lupus erythematosus patients with and without neuropsychiatric manifestations: a neck and transcranial duplex sonography study 20
Reply Letter - Polypharmacy is a determinant of hospitalization in Parkinson's disease 20
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 19
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 19
Secukinumab-induced subacute cutaneous lupus erythematosus 19
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 19
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 19
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 19
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 18
Totale 5.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/2026653 490 163 0 0 0 0 0 0 0 0 0 0
Totale 6.166